Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain.

M. A. Mehta, A. M. Owen, B. J. Sahakian, N. Mavaddat, J. D. Pickard, T. W. Robbins

Research output: Contribution to journalArticle

374 Citations (Scopus)

Abstract

The indirect catecholamine agonist methylphenidate (Ritalin) is the drug treatment of choice in attention deficit/hyperactivity disorder (AD/HD), one of the most common behavioral disorders of childhood (DSM-IV), although symptoms may persist into adulthood. Methylphenidate can enhance cognitive performance in adults and children diagnosed with AD/HD (Kempton et al., 1999; Riordan et al., 1999) and also in normal human volunteers on tasks sensitive to frontal lobe damage, including aspects of spatial working memory (SWM) performance (Elliott et al., 1997). The present study investigated changes in regional cerebral blood flow (rCBF) induced by methylphenidate during performance of a self-ordered SWM task to define the neuroanatomical loci of the beneficial effect of the drug. The results show that the methylphenidate-induced improvements in working memory performance occur with task-related reductions in rCBF in the dorsolateral prefrontal cortex and posterior parietal cortex. The beneficial effects of methylphenidate on working memory were greatest in the subjects with lower baseline working memory capacity. This is to our knowledge the first demonstration of a localization of a drug-induced improvement in SWM performance in humans and has relevance for understanding the treatment of AD/HD.

Original languageEnglish
JournalThe Journal of neuroscience : the official journal of the Society for Neuroscience
Volume20
Issue number6
Publication statusPublished - 1 Jan 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain.'. Together they form a unique fingerprint.

Cite this